NDC 65302-062
Tafluprost
Tafluprost
Tafluprost is a Ophthalmic Solution in the Human Prescription Drug category. It is labeled and distributed by The Ritedose Corporation. The primary component is Tafluprost.
| Product ID | 65302-062_f05e2b3e-be98-5187-e053-2a95a90a1067 |
| NDC | 65302-062 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Tafluprost |
| Generic Name | Tafluprost |
| Dosage Form | Solution |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2022-12-05 |
| Marketing Category | ANDA / |
| Application Number | ANDA209040 |
| Labeler Name | The Ritedose Corporation |
| Substance Name | TAFLUPROST |
| Active Ingredient Strength | 0 mg/.3mL |
| Pharm Classes | Increased Prostaglandin Activity [PE], Prostaglandin Analog [EPC], Prostaglandin Receptor Agonists [MoA], Prostaglandins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |